Filing Details
- Accession Number:
- 0001493152-22-018552
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-05 16:44:17
- Reporting Period:
- 2022-06-30
- Accepted Time:
- 2022-07-05 16:44:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1641631 | Beyond Air Inc. | XAIR | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1251213 | Ron Bentsur | C/O Beyond Air, Inc. 900 Stewart Avenue, Suite 301 Garden City NY 11530 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-06-30 | 40,000 | $6.53 | 142,436 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sale was made to satisfy an Israeli tax obligation resulting from the reporting person's ownership of shares of Advanced Inhalation Therapies (AIT) Ltd., an Israeli corporation, which merged with Beyond Air, Inc. (formerly known as AIT Therapeutics, Inc.), a Delaware corporation, on January 13, 2017.
- The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.50 to $6.57, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.